Sign in
Not yet taking people in United StatesPhase 2

Inulin fiber supplement for inflammation and knee pain in knee osteoarthritis

Tests inulin fiber against placebo for inflammation and pain in older adults with knee osteoarthritis.

Key facts

Who runs it
Yale University
Where
West Haven, United StatesSee the site
Trial code
Registry title
Inulin Supplementation for Reducing Inflammation and Knee Pain in Older Adults With Osteoarthritis
Status
Not yet recruiting
Phase
Phase 2
People taking part
84 people, planned
Started
1 Nov 2026
Expected to end
31 Jul 2027
Type of study
Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • inulin
  • Maltodextrin (Placebo)
Record updated
7 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 40 or older with knee osteoarthritis and knee pain. They must be patients of the VA Connecticut Healthcare System.

Age
40 years or older
Sex
All sexes
Disease stage
Knee osteoarthritis, Kellgren-Lawrence grade 2-4 on an X-ray from the past 2 years. Pain of at least 4/10 in one knee in the past week. Knee pain on most days of the past month.
Earlier treatment
No antibiotics in the past 6 months. No anti-inflammatory supplements such as turmeric or omega-3 fatty acids in the past 30 days. No investigational drug in the past 30 days.

Main reasons for not taking part

  • Pre-diabetes or diabetes (Type 1 or Type 2)
  • Current use of medicines that strongly affect gut bacteria, such as proton pump inhibitors, disease-modifying antirheumatic drugs or GLP-1 receptor agonists
  • Current tai chi, acupuncture or yoga for knee osteoarthritis
  • Serious gut disease, such as inflammatory bowel disease or an active stomach ulcer
  • Pregnancy, alcohol use disorder, or allergy to inulin or maltodextrin

The registry criteria, word for word

Show all 22 criteriaShow less

Who can take part

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study (8 weeks)
  • Male or female, aged ≥ 40 years
  • Established patient in the VA Connecticut Healthcare System
  • At least one knee with pain severity in the past week ≥ 4/10 on numerical rating scale (NRS)
  • Self-reported knee pain on most days of the prior month
  • Diagnosed with knee osteoarthritis (Kellgren-Lawrence grade 2-4 on radiographic imaging within the past 2 years)
  • Ability to take oral powder supplements and willingness to adhere to the inulin/placebo daily regimen
  • Agreement to adhere to lifestyle considerations (see Section 5.3) throughout study duration, including maintenance of current diet, physical activity, and avoidance of new dietary supplements or complementary therapies
  • English-speaking and able to provide informed consent
  • For females of reproductive potential: use of highly effective contraception for at least 1 month prior to screening and agreement to continue such method during study participation

Who cannot take part

  • Participation in another interventional study or use of an investigational drug within the past 30 days
  • Current use of complementary or integrative therapies for knee OA including tai chi, acupuncture or yoga
  • Current use of medications known to significantly impact the gut microbiome (e.g., proton pump inhibitors, disease-modifying antirheumatic drugs, GLP-1 receptor agonists)
  • Known allergy or intolerance to components of the study intervention, including inulin or maltodextrin
  • The presence of significant gastrointestinal disease that may interfere with the intervention or outcomes, such as inflammatory bowel disease or active peptic ulcer disease
  • Any medical, psychological, or behavioral condition that, in the opinion of the investigators, would place the participant at undue risk, interfere with study participation or adherence, or compromise data integrity
  • Current diagnosis of alcohol use disorder
  • Current diagnosis of pre-diabetes (impaired glucose tolerance) or diabetes mellitus (Type 1 or Type 2)
  • Use of antibiotics within the past 6 months
  • Use of anti-inflammatory dietary supplements (e.g., turmeric, omega-3 fatty acids) within the past 30 days
  • Pregnancy

Where in United States

  • VA Connecticut Healthcare System, West Haven CampusWest Haven, United StatesContact: Evelyn Hsieh, MD, PhDNot yet recruiting

About the trial

What the trial wants to find out

This study will test whether inulin, a type of dietary fiber, can reduce inflammation in older adults with knee osteoarthritis. Inflammation in the body may contribute to both joint pain and the progression of osteoarthritis. Inulin is a prebiotic fiber that may improve gut health and reduce lipopolysaccharide (LPS), a marker of bacterial products in the blood that is linked to inflammation.

Read full original descriptionShow less

In this trial, participants with knee osteoarthritis will be randomly assigned to receive either inulin or a placebo (maltodextrin) for 8 weeks. The study will measure changes in blood LPS levels, knee pain, and other markers of inflammation. The goal is to determine whether inulin supplementation can improve pain and reduce inflammation in people with knee osteoarthritis.

The 3 groups in the trial

  • Placebo (Maltodextrin)Placebo, for comparison

    Participants receive maltodextrin powder in identical sachets. Dose is escalated over 2 weeks to match the dosing schedule of the inulin arms (5 g daily for 3 days, 10 g daily for 4 days, then 15 g daily). Sachets are mixed with food or beverage and taken once daily with the largest meal, for 8 weeks.

    Treatment: Maltodextrin (Placebo)

  • Inulin 10 g/dayTreatment being tested

    Participants receive inulin powder in identical sachets. Dose is escalated to 10 g daily (5 g daily for 3 days, then 10 g daily for 4 days). After Week 2, participants continue with one 15 g sachet containing a 2:1 blend of inulin and maltodextrin, providing a daily dose of 10 g inulin. Sachets are mixed with food or beverage and taken once daily with the largest meal, for 8 weeks.

    Treatment: inulin

  • Inulin 15 g/dayTreatment being tested

    Participants receive inulin powder in identical sachets. Dose is escalated to 15 g daily (5 g daily for 3 days, 10 g daily for 4 days, then 15 g daily). Sachets are mixed with food or beverage and taken once daily with the largest meal, for 8 weeks.

    Treatment: inulin

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Change in LPS With Inulin Supplementation and Its Association With Knee Pain Among Older Adults With Osteoarthritis
Plain-language title
Inulin fiber supplement for inflammation and knee pain in knee osteoarthritisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
7 July 2026